Form 8-K - Current report:
SEC Accession No. 0001213900-25-053051
Filing Date
2025-06-10
Accepted
2025-06-10 16:00:16
Documents
15
Period of Report
2025-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0245174-8k_inmune.htm   iXBRL 8-K 41098
2 SECOND AMENDED AND RESTATED INMUNE BIO INC. 2021 STOCK INCENTIVE PLAN ea024517401ex10-1_inmune.htm EX-10.1 114727
3 PRESS RELEASE, DATED JUNE 10, 2025 ea024517401ex99-1_inmune.htm EX-99.1 15755
4 GRAPHIC ex99-1_001.jpg GRAPHIC 4663
  Complete submission text file 0001213900-25-053051.txt   378940

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE inmb-20250610.xsd EX-101.SCH 3017
6 XBRL LABEL FILE inmb-20250610_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE inmb-20250610_pre.xml EX-101.PRE 22360
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0245174-8k_inmune_htm.xml XML 3679
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 251036996
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)